Similar trends have been observed not only in FMR patients with high-risk factors for HF development, such as reduced cardiac function, left ventricular hypertrophy, and elevated BNP levels, but also in DMR patients, suggesting that GNRI alone is difficult to predict for HFH after TEER, regardless of MR etiology. The gene discussed is NPPB; the disease is left ventricular hypertrophy.